Promising New Developments In AI: Innovating To Drive Efficiency And Quality In Clinical Trials

By Jonas Renström, Director, Digital Strategy & Innovation, and Laurence Lin, Associate Director, AI Scientist

The landscape of clinical research is transforming as artificial intelligence moves from conceptual "blue sky ideation" into practical, high-impact applications. Modern advancements in Generative and agentic AI are now driving significant improvements in both the efficiency and quality of clinical trials. Unlike standard consumer models, which can be prone to hallucinations in scientific contexts, specialized "healthcare-grade" AI utilizes curated, containerized datasets to ensure medical-grade precision.

Success in this field relies on five foundational safeguards: curating data within strict boundaries, maintaining a "human-in-the-loop" for critical decisions, harmonizing responses across diverse query styles, ensuring objective analysis of medical data, and training models to recognize their own knowledge gaps. Real-world implementations already include conversational chatbots that provide rapid protocol clarifications for site staff, as well as sophisticated data review tools capable of objectively grading the severity of adverse events. By integrating these intelligent agents into complex workflows, researchers can automate administrative tasks while reserving human expertise for the most sensitive scientific interpretations. This balanced approach not only accelerates trial timelines but also enhances the overall safety and reliability of the data generated.